Stocks and Investing
by (remove) : Patrick Trucchio
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Patrick Trucchio
RSSJSONXMLCSV
Thu, September 5, 2024
Tue, September 3, 2024
Fri, August 30, 2024
Thu, August 22, 2024
Tue, August 20, 2024
Wed, July 31, 2024
Tue, July 23, 2024
Fri, July 5, 2024
Mon, June 24, 2024
Tue, June 11, 2024
Wed, June 5, 2024
Mon, June 3, 2024
Fri, May 24, 2024
Fri, May 17, 2024
Thu, May 16, 2024
Tue, May 14, 2024
Mon, May 13, 2024
Tue, May 7, 2024
Wed, April 3, 2024
Mon, April 1, 2024
Wed, March 27, 2024
Tue, March 19, 2024
Fri, March 15, 2024

Patrick Trucchio Reiterated (ARWR) at Strong Buy and Held Target at $60 on, Sep 5th, 2024


Published on 2024-10-28 14:05:32 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $60 on, Sep 5th, 2024.

Patrick has made no other calls on ARWR in the last 4 months.



There are 5 other peers that have a rating on ARWR. Out of the 5 peers that are also analyzing ARWR, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024


These are the ratings of the 3 analyists that currently disagree with Patrick


  • Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $55 on, Monday, August 12th, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Wednesday, July 17th, 2024
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Buy on, Thursday, June 20th, 2024
Contributing Sources